MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galectin Therapeutics (GALT) Ownership - Who owns Galectin Therapeutics?
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
152.53M
P/E Ratio
N/A
Total Cash
7.43M
Projected Growth
N/A
Total Debt
107.99M
Revenue
N/A
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash/Share
0.12
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GALT
Capitalization
153M
P/E Ratio
N/A
Risk (Beta)
0.38
Dividend Yield
N/A
Total Cash
7.43M
Total Cash/Share
0.12
Total Debt
108M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-114.48M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
63K
Current Ratio
0.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-38.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-255.85
Shares Held By Institutions
18.3M
Shares Outstanding - Current
63.3M
Total Liabilities
122M
Total Volume MTD
N/A
Value
-1
Gain YTD
87.597
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com